Investigational Drug Shows Potentialin Phase 3 Obesity Trial
-
By
-
Andrea Surnit
-
June 10, 2026
-
4 min
By
Andrea Surnit
June 10, 2026
A large BRFSS analysis points to persistent screening disparities among sexual orientation and gender identity minority respondents, with particularly large gaps in some gender identity minority groups.
July 9, 2026
In a pooled analysis of two randomized crossover trials, reducing nightly sleep by about 1.5 hours for 6 weeks was associated with modest increases in body weight and waist circumference without measurable changes in body composition.
July 9, 2026